Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes

A Mari, W M Sallas, Y L He, C Watson, M Ligueros-Saylan, B E Dunning, C F Deacon, Jens Juul Holst, J E Foley

334 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes'. Sammen danner de et unikt fingeraftryk.

Kemiske forbindelser

Medicin og biovidenskab